DRUGS IN THE ELDERLYREIDENBERG MM.1980; BULL. N.Y. ACAD. MED.; ISSN 0028-7091; USA; DA. 1980; VOL. 56; NO 8; PP. 703-714; BIBL. 44 REF.Article

THE BINDING OF DRUGS TO PLASMA PROTEINS FROM PATIENTS WITH POOR RENAL FUNCTIONREIDENBERG MM.1976; CLIN. PHARMACOKINET.; NETHERL.; DA. 1976; VOL. 1; NO 2; PP. 121-125; BIBL. 1 P. 1/2Article

EFFECT OF DISEASE STATES ON LASMA PROTEIN BINDING OF DRUGS = EFFET DES ETATS PATHOLOGIQUES SUR LA FIXATION DES DROGUES AUX PROTEINES DU PLASMAREIDENBERG MM.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1103-1109; BIBL. 19REF.Article

ENVIRONMENTAL FACTORS IN RENAL DISEASEREIDENBERG MM.1981; CLIN. EXP. DIAL. APHERESIS; USA; DA. 1981; VOL. 5; NO 1-2; PP. 101-109; BIBL. 26 REF.Conference Paper

SYMPTOMATIC HYPOKALEMIA RESULTING FROM SURREPTITIOUS DIURETIC INGESTIONRODMAN JS; REIDENBERG MM.1981; JAMA, J. AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1981; VOL. 246; NO 15; PP. 1687-1689; BIBL. 13 REF.Article

CLINICAL CONSEQUENCES OF POLYMORPHIC ACETYLATION OF BASIC DRUGS.DRAYER DE; REIDENBERG MM.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 22; NO 3; PP. 251-258; BIBL. 2 P. 1/2Article

IN VITRO RESPONSE OF RAT AND HUMAN KIDNEY LYSOSOMES TO AMINOGLYCOSIDESPOWELL JH; REIDENBERG MM.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 21; PP. 3447-3453; BIBL. 35 REF.Article

SERUM DIGOXIN CONCENTRATION AND AGEGUGGENHEIM R; REIDENBERG MM.1980; J. AM. GERIATR. SOC.; ISSN 0002-8614; USA; DA. 1980; VOL. 28; NO 12; PP. 553-555; BIBL. 8 REF.Article

THE BINDING OF THEOPHYLLINE TO SERUM PROTEINS OF HEMODIALYSIS PATIENTSREIDENBERG MM; RESTIVO K.1979; J. DIALYS.; USA; DA. 1979 PUBL. 1980; VOL. 3; NO 4; PP. 375-381; BIBL. 8 REF.Article

THE PROTEIN BINDING OF SOME DRUGS IN PLASMA FROM PATIENTS WITH ALCOHOLIC LIVER DISEASE = LA FIXATION AUX PROTEINES DE QUELQUES MEDICAMENTS DANS LE PLASMA DE PATIENTS AVEC UNE AFFECTION HEPATIQUE ALCOOLIQUEAFFRIME M; REIDENBERG MM.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 8; NO 3-4; PP. 267-269; BIBL. 10REF.Serial Issue

LIQUID CHROMATOGRAPHY AND FLUORESCENCE SPECTROSCOPY COMPARED WITH HOMOGENEOUS ENZYME IMMUNOASSAY TECHNIQUE FOR DETERMINING QUINIDINE IN SERUMDRAYER DE; LORENZO B; REIDENBERG MM et al.1981; CLIN. CHEM.; ISSN 0009-9147; USA; DA. 1981; VOL. 27; NO 2; PP. 308-310; BIBL. 9 REF.Article

SPECIFIC DETERMINATION OF QUINIDINE AND (3S)-3-HYDROXY-QUINIDINE IN HUMAN SERUM BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY.DRAYER DE; RESTIVO K; REIDENBERG MM et al.1977; J. LAB. CLIN. MED.; U.S.A.; DA. 1977; VOL. 90; NO 5; PP. 816-822; BIBL. 12 REF.Article

N-ACETYLPROCAINAMIDE: AN ACTIVE METABOLITE OF PROCAINAMIDEDRAYER DE; REIDENBERG MM; SEVY RW et al.1974; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1974; VOL. 146; NO 2; PP. 358-363; BIBL. 23REF.Article

EVALUATING PATIENTS' WARFARIN REQUIREMENTSJONES BR; ANDRIJ BARAN; REIDENBERG MM et al.1980; J. AMER. GERIATR. SOC.; USA; DA. 1980; VOL. 28; NO 1; PP. 10-12; BIBL. 5 REF.Article

AGE AND RENAL CLEARANCE OF CIMETIDINEDRAYER DE; ROMANKIEWICZ J; LORENZO B et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 1; PP. 45-50; BIBL. 29 REF.Article

UNUSUAL CAUSE OF THEOPHYLLINE TOXICITYGOTZ VP; DRAYER DE; SCHNED ES et al.1979; NEW YORK STATE J. MED.; USA; DA. 1979; VOL. 79; NO 8; PP. 1232-1234; BIBL. 17 REF.Article

POLYMORPHIC ACETYLATION OF PROCAINAMIDE IN MAN = POLYMORPHISME DE L'ACETYLATION DU PROCAINAMIDE CHEZ L'HOMMEREIDENBERG MM; DRAYER DE; LEVY M et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 6; PP. 722-730; BIBL. 1P.Article

REMOVAL OF MERCURY BY PERITONEAL DIALYSISLOWENTHAL DT; CHARDO F; REIDENBERG MM et al.1974; ARCH. INTERN. MED.; U.S.A.; DA. 1974; VOL. 134; NO 1; PP. 139-141; BIBL. 20REF.Article

ACETYLPROCAINAMIDE THERAPY IN PATIENTS WITH PREVIOUS PROCAINAMIDE-INDUCED LUPUS SYNDROMEKLUGER J; DRAYER DE; REIDENBERG MM et al.1981; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1981; VOL. 95; NO 1; PP. 18-23; BIBL. 19 REF.Article

ANTIARRHYTHMIC ACTIVITY OF P-HYDROXY-N-(2-DIETHYLAMINOETHYL) BENZAMIDE (THE P-HYDROXY ISOSTERE OF PROCAINAMIDE) IN DOGS AND MICE.DRAYER DE; SLAVEN BH; REIDENBERG MM et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 2; PP. 270-274; BIBL. 29 REF.Article

IN VITRO ACETYLATION OF DRUGS BY HUMAN BLOOD CELLSDRAYER DE; STRONG JM; JONES B et al.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 6; PP. 499-505; BIBL. 37REF.Article

N-ACETYL-BETA -GLUCOSAMINIDASE AND BETA _D2-MICROGLOBULIN. THEIR URINARY EXCRETION IN PATIENTS WITH RENAL PARENCHYMAL DISEASESHERMAN RL; DRAYER DE; LEYLAND JONES BR et al.1983; ARCHIVES OF INTERNAL MEDICINE (1960); ISSN 0003-9926; USA; DA. 1983; VOL. 143; NO 6; PP. 1183-1185; BIBL. 15 REF.Article

MICROSOMAL HYDROXYLATION AS MEASURED BY PENTOBARBITAL ELIMINATION IN PATIENTS WITH IDIOPATHIC SYSTEMIC LUPUS ERYTHEMATOSUSDRAYER DE; LORENZO B; LAHITA RG et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 2; PP. 195-200; BIBL. 33 REF.Article

CUMULATION OF N-ACETYLPROCAINAMIDE, AN ACTIVE METABOLITE OF PROCAINAMIDE, IN PATIENTS WITH IMPAIRED RENAL FUNCTION.DRAYER DE; LOWENTHAL DT; WOOSLEY RL et al.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 22; NO 1; PP. 63-69; BIBL. 14 REF.Article

KINETICS OF METOPRINE, A LIPID-SOLUBLE ANTIFOLATEJONES BR; GORDON CS; UMANS J et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 5; PP. 675-680; BIBL. 17 REF.Article